Third Harmonic Bio Stock Analysis
THRD Stock | USD 3.49 0.03 0.87% |
Third Harmonic Bio is fairly valued with Real Value of 3.39 and Target Price of 19.0. The main objective of Third Harmonic stock analysis is to determine its intrinsic value, which is an estimate of what Third Harmonic Bio is worth, separate from its market price. There are two main types of Third Harmonic's stock analysis: fundamental analysis and technical analysis.
The Third Harmonic stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Third Harmonic's ongoing operational relationships across important fundamental and technical indicators.
Third |
Third Stock Analysis Notes
About 91.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.53. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Third Harmonic Bio recorded a loss per share of 0.98. The entity last dividend was issued on the August 6, 2014. The firm had 105:100 split on the February 11, 2011. Third Harmonic Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development of the medicine for the treatment of allergic and inflammatory diseases. Third Harmonic Bio, Inc. was founded in 2019 and is headquartered in Cambridge, Massachusetts. Third Harmonic operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 16 people. To find out more about Third Harmonic Bio contact Natalie Holles at 209 727 2457 or learn more at https://www.thirdharmonicbio.com.Third Harmonic Bio Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Third Harmonic's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Third Harmonic Bio or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Third Harmonic Bio generated a negative expected return over the last 90 days | |
Third Harmonic Bio has high historical volatility and very poor performance | |
Net Loss for the year was (30.82 M) with profit before overhead, payroll, taxes, and interest of 0. | |
Third Harmonic Bio currently holds about 112.73 M in cash with (20.43 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 25.53, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
Over 91.0% of the company shares are owned by institutional investors | |
Latest headline from finance.yahoo.com: Third Harmonic Bio Initiates Strategic Review, Lays Off 50 percent Staff Citing Competitive Landscape |
Third Harmonic Bio Upcoming and Recent Events
3rd of April 2024 Upcoming Quarterly Report | View | |
9th of May 2024 Next Financial Report | View | |
31st of December 2023 Next Fiscal Quarter End | View | |
3rd of April 2024 Next Fiscal Year End | View | |
30th of September 2023 Last Quarter Report | View | |
31st of December 2022 Last Financial Announcement | View |
Third Largest EPS Surprises
Earnings surprises can significantly impact Third Harmonic's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
---|---|---|---|---|---|---|---|
2024-11-07 | 2024-09-30 | -0.29 | -0.33 | -0.04 | 13 | ||
2024-08-08 | 2024-06-30 | -0.2633 | -0.22 | 0.0433 | 16 | ||
2023-11-09 | 2023-09-30 | -0.27 | -0.19 | 0.08 | 29 |
Third Harmonic Environmental, Social, and Governance (ESG) Scores
Third Harmonic's ESG score is a quantitative measure that evaluates Third Harmonic's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Third Harmonic's operations that may have significant financial implications and affect Third Harmonic's stock price as well as guide investors towards more socially responsible investments.
Third Stock Institutional Investors
Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares | Ra Capital Management, Llc | 2024-12-31 | 960.6 K | Millennium Management Llc | 2024-12-31 | 640.1 K | Citadel Advisors Llc | 2024-09-30 | 608.2 K | Nantahala Capital Management, Llc | 2024-12-31 | 501 K | Geode Capital Management, Llc | 2024-12-31 | 481.9 K | State Street Corp | 2024-12-31 | 421.8 K | T. Rowe Price Associates, Inc. | 2024-12-31 | 361.9 K | Schonfeld Strategic Advisors Llc | 2024-12-31 | 322.2 K | Commodore Capital Lp | 2024-12-31 | 237.7 K | Orbimed Advisors, Llc | 2024-09-30 | 5.8 M | General Atlantic Llc | 2024-12-31 | 3.4 M |
Third Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 157.25 M.Third Profitablity
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (0.10) | (0.10) | |
Return On Capital Employed | (0.16) | (0.15) | |
Return On Assets | (0.10) | (0.10) | |
Return On Equity | (0.11) | (0.13) |
Management Efficiency
Third Harmonic Bio has return on total asset (ROA) of (0.1126) % which means that it has lost $0.1126 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.1381) %, meaning that it created substantial loss on money invested by shareholders. Third Harmonic's management efficiency ratios could be used to measure how well Third Harmonic manages its routine affairs as well as how well it operates its assets and liabilities. As of February 27, 2025, Return On Tangible Assets is expected to decline to -0.1. The current year's Return On Capital Employed is expected to grow to -0.15. The current year's Other Assets is expected to grow to 1.21, whereas Total Assets are forecasted to decline to about 196.3 M.Last Reported | Projected for Next Year | ||
Book Value Per Share | 6.11 | 6.41 | |
Tangible Book Value Per Share | 6.11 | 6.41 | |
Enterprise Value Over EBITDA | (4.96) | (5.21) | |
Price Book Value Ratio | 1.45 | 1.53 | |
Enterprise Value Multiple | (4.96) | (5.21) | |
Price Fair Value | 1.45 | 1.53 | |
Enterprise Value | -103.7 M | -108.9 M |
The strategic initiatives led by Third Harmonic's management are central to its market success. By analyzing these initiatives, we provide a clear picture of the stock's growth prospects.
Technical Drivers
As of the 27th of February, Third Harmonic has the Variance of 43.44, coefficient of variation of (394.96), and Risk Adjusted Performance of (0.18). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Third Harmonic Bio, as well as the relationship between them. Please validate Third Harmonic Bio variance and value at risk to decide if Third Harmonic is priced more or less accurately, providing market reflects its prevalent price of 3.49 per share. Given that Third Harmonic Bio has information ratio of (0.25), we advise you to double-check Third Harmonic Bio's current market performance to make sure the company can sustain itself at a future point.Third Harmonic Bio Price Movement Analysis
The output start index for this execution was nineteen with a total number of output elements of fourty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Third Harmonic middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Third Harmonic Bio. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Third Harmonic Bio Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Third Harmonic insiders, such as employees or executives, is commonly permitted as long as it does not rely on Third Harmonic's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Third Harmonic insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Third Harmonic Outstanding Bonds
Third Harmonic issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Third Harmonic Bio uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Third bonds can be classified according to their maturity, which is the date when Third Harmonic Bio has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Dana 575 percent Corp BondUS235822AB96 | View | |
MPLX LP 4125 Corp BondUS55336VAK61 | View | |
MPLX LP 52 Corp BondUS55336VAL45 | View | |
BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
MGM Resorts International Corp BondUS552953CD18 | View | |
Valero Energy Partners Corp BondUS91914JAA07 | View |
Third Harmonic Predictive Daily Indicators
Third Harmonic intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Third Harmonic stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Third Harmonic Corporate Filings
14th of February 2025 Other Reports | ViewVerify | |
13th of February 2025 Other Reports | ViewVerify | |
12th of February 2025 Other Reports | ViewVerify | |
8K | 11th of February 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
22nd of January 2025 Other Reports | ViewVerify | |
F4 | 17th of January 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
13A | 14th of November 2024 The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934 | ViewVerify |
F4 | 12th of November 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
Third Harmonic Forecast Models
Third Harmonic's time-series forecasting models are one of many Third Harmonic's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Third Harmonic's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Third Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Third Harmonic prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Third shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Third Harmonic. By using and applying Third Stock analysis, traders can create a robust methodology for identifying Third entry and exit points for their positions.
Last Reported | Projected for Next Year |
Current Third Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Third analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Third analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Price | Advice | # of Analysts | |
19.0 | Strong Buy | 6 | Odds |
Most Third analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Third stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Third Harmonic Bio, talking to its executives and customers, or listening to Third conference calls.
Third Stock Analysis Indicators
Third Harmonic Bio stock analysis indicators help investors evaluate how Third Harmonic stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Third Harmonic shares will generate the highest return on investment. By understating and applying Third Harmonic stock analysis, traders can identify Third Harmonic position entry and exit signals to maximize returns.
Begin Period Cash Flow | 289.3 M | |
Total Stockholder Equity | 269.1 M | |
Capital Lease Obligations | 4 M | |
Property Plant And Equipment Net | 3.9 M | |
Cash And Short Term Investments | 269.1 M | |
Net Invested Capital | 269.1 M | |
Cash | 269.1 M | |
200 Day M A | 11.3881 | |
50 Day M A | 7.1819 | |
Net Interest Income | 13.1 M | |
Total Current Liabilities | 5.4 M | |
Investments | -204 K | |
Stock Based Compensation | 9.6 M | |
Common Stock Shares Outstanding | 39.6 M | |
Free Cash Flow | -20.6 M | |
Operating Income | -44 M | |
Other Current Assets | 3.4 M | |
Accounts Payable | 1.8 M | |
Net Debt | -265.1 M | |
Depreciation | 35 K | |
Other Operating Expenses | 44 M | |
Non Current Assets Total | 5.3 M | |
Liabilities And Stockholders Equity | 277.7 M | |
Non Currrent Assets Other | 1.3 M |
Complementary Tools for Third Stock analysis
When running Third Harmonic's price analysis, check to measure Third Harmonic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Third Harmonic is operating at the current time. Most of Third Harmonic's value examination focuses on studying past and present price action to predict the probability of Third Harmonic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Third Harmonic's price. Additionally, you may evaluate how the addition of Third Harmonic to your portfolios can decrease your overall portfolio volatility.
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
CEOs Directory Screen CEOs from public companies around the world | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data |